See more : Montebalito, S.A. (MTB.MC) Income Statement Analysis – Financial Results
Complete financial analysis of Magellan Health, Inc. (MGLN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Magellan Health, Inc., a leading company in the Medical – Healthcare Plans industry within the Healthcare sector.
- Chosun Refractories Co.,Ltd. (000480.KS) Income Statement Analysis – Financial Results
- Wyncrest Group, Inc. (WNCG) Income Statement Analysis – Financial Results
- Hunan Jingfeng Pharmaceutical Co.,Ltd. (000908.SZ) Income Statement Analysis – Financial Results
- Volpara Health Technologies Limited (VPAHF) Income Statement Analysis – Financial Results
- Bit Brother Limited (BETS) Income Statement Analysis – Financial Results
Magellan Health, Inc. (MGLN)
About Magellan Health, Inc.
Magellan Health, Inc., together with its subsidiaries, provides healthcare management services in the United States. The company operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans; and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine. It also contracts with state Medicaid agencies, and the centers for Medicare and Medicaid services to manage care for beneficiaries under Medicaid and Medicare programs, such as healthcare and long-term support services through its network of medical and behavioral health professionals, clinics, hospitals, nursing facilities, home care agencies, and ancillary service providers. The Pharmacy Management segment comprises products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Further, it offers pharmacy benefit management services, such as pharmaceutical dispensing services; pharmacy benefit administration for state Medicaid and other government sponsored programs; clinical and formulary management programs; medical pharmacy management programs; and programs for the integrated management of specialty drugs that treat complex conditions. In addition, the company provides services to health plans and managed care organizations, employers, labor unions, third party administrators, state governments, military and governmental agencies, exchanges, brokers, and consultants. Magellan Health, Inc. was incorporated in 1969 and is headquartered in Phoenix, Arizona. As of January 4, 2022, Magellan Health, Inc. operates as a subsidiary of Centene Corporation.
Metric | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 4.58B | 7.16B | 7.31B | 5.84B | 4.84B | 4.60B | 3.76B | 3.55B | 3.21B | 2.80B | 2.97B | 2.64B | 2.63B | 2.16B | 1.69B | 1.81B | 1.80B | 1.51B | 445.89M | 1.76B | 1.87B | 1.87B | 1.51B | 1.21B | 1.35B | 1.15B | 904.65M |
Cost of Revenue | 4.46B | 6.93B | 7.12B | 5.57B | 4.58B | 4.42B | 3.55B | 3.31B | 2.96B | 2.02B | 2.13B | 2.43B | 2.44B | 1.96B | 1.51B | 1.57B | 0.00 | 1.32B | 0.00 | 1.56B | 1.65B | 1.66B | 1.29B | 978.51M | 0.00 | 0.00 | 0.00 |
Gross Profit | 118.79M | 229.29M | 197.18M | 271.02M | 258.94M | 178.38M | 215.08M | 238.19M | 249.58M | 782.64M | 842.63M | 207.46M | 186.87M | 193.26M | 181.90M | 241.62M | 1.80B | 185.86M | 445.89M | 198.47M | 220.97M | 208.01M | 217.97M | 232.18M | 1.35B | 1.15B | 904.65M |
Gross Profit Ratio | 2.60% | 3.20% | 2.70% | 4.64% | 5.35% | 3.88% | 5.72% | 6.72% | 7.78% | 27.96% | 28.38% | 7.85% | 7.12% | 8.96% | 10.76% | 13.36% | 100.00% | 12.30% | 100.00% | 11.31% | 11.79% | 11.11% | 14.41% | 19.18% | 100.00% | 100.00% | 100.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.59B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 0.00 | 0.00 | 0.00 | 0.00 | 876.61M | 822.39M | 723.50M | 619.55M | 557.51M | 529.63M | 566.58M | 0.00 | 0.00 | 0.00 | 0.00 | 15.81M | 1.59B | 0.00 | 391.43M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Expenses | 98.39M | 131.51M | 132.66M | 115.71M | -770.57M | -719.55M | -632.43M | -547.55M | -497.02M | 58.62M | 54.68M | 47.27M | 60.81M | 57.52M | 48.86M | 49.09M | 42.49M | 358.06M | 14.38M | 35.07M | 91.02M | 63.79M | 103.54M | 163.71M | 1.23B | 1.15B | 922.79M |
Operating Expenses | 98.39M | 131.51M | 132.66M | 115.71M | 106.05M | 102.84M | 91.07M | 71.99M | 60.49M | 588.26M | 621.26M | 47.27M | 60.81M | 57.52M | 48.86M | 64.90M | 1.63B | 358.06M | 405.81M | 35.07M | 91.02M | 63.79M | 103.54M | 163.71M | 1.23B | 1.15B | 922.79M |
Cost & Expenses | 4.56B | 7.06B | 7.25B | 5.68B | 4.68B | 4.52B | 3.64B | 3.38B | 3.02B | 2.61B | 2.75B | 2.48B | 2.50B | 2.02B | 1.56B | 1.63B | 1.63B | 1.68B | 405.81M | 1.59B | 1.74B | 1.73B | 1.40B | 1.14B | 1.23B | 1.15B | 922.79M |
Interest Income | 4.05M | 19.19M | 14.07M | 5.89M | 2.82M | 2.17M | 1.30M | 1.99M | 2.02M | 2.78M | 3.28M | 6.25M | 17.03M | 23.84M | 17.63M | 17.46M | 6.13M | 2.87M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 30.87M | 36.15M | 35.40M | 25.98M | 10.19M | 6.58M | 7.39M | 3.00M | 2.25M | 2.50M | 2.23M | 2.42M | 2.85M | 6.39M | 7.29M | 44.01M | 37.12M | 61.02M | 873.00K | -8.80M | -83.00M | -18.41M | -38.31M | -14.36M | -6.16M | 0.00 | -12.62M |
Depreciation & Amortization | 118.75M | 131.51M | 132.66M | 115.71M | 106.05M | 102.84M | 91.07M | 71.99M | 60.49M | 58.62M | 54.68M | 47.27M | 60.81M | 57.52M | 48.86M | 49.09M | 42.49M | 48.05M | 14.38M | 70.28M | 79.24M | 73.53M | 54.89M | 44.86M | 48.92M | 64.09M | 59.55M |
EBITDA | 487.41M | 248.48M | 211.25M | 276.97M | 263.85M | 183.25M | 221.55M | 240.18M | 251.60M | 255.79M | 279.32M | 213.70M | 203.90M | 216.74M | 205.11M | 306.09M | 214.57M | 594.65M | 29.24M | 131.22M | 28.91M | 105.60M | 55.64M | 53.60M | 107.00M | 9.82M | -10.60M |
EBITDA Ratio | 10.65% | 3.47% | 2.89% | 4.74% | 5.45% | 3.99% | 5.89% | 6.77% | 7.84% | 9.14% | 9.41% | 8.09% | 7.77% | 10.05% | 12.13% | 16.93% | 11.95% | 39.36% | 6.56% | 7.47% | 1.54% | 5.64% | 3.68% | 4.43% | 7.95% | 0.85% | -1.17% |
Operating Income | 368.67M | 116.97M | 78.59M | 161.27M | 157.80M | 80.40M | 130.48M | 168.19M | 191.11M | 197.16M | 224.64M | 166.43M | 143.09M | 159.21M | 156.25M | 257.00M | 172.08M | 546.60M | 14.86M | 60.94M | -50.33M | 32.06M | 750.00K | 8.74M | 58.08M | -54.27M | -70.16M |
Operating Income Ratio | 8.05% | 1.63% | 1.07% | 2.76% | 3.26% | 1.75% | 3.47% | 4.74% | 5.96% | 7.04% | 7.57% | 6.30% | 5.45% | 7.38% | 9.24% | 14.21% | 9.58% | 36.18% | 3.33% | 3.47% | -2.69% | 1.71% | 0.05% | 0.72% | 4.32% | -4.71% | -7.75% |
Total Other Income/Expenses | -409.15M | -36.15M | -35.40M | -26.04M | -12.28M | -9.29M | -12.56M | -3.00M | -2.25M | -2.50M | -2.23M | -2.42M | -2.85M | -6.03M | -7.33M | -45.54M | -40.54M | -60.82M | -873.00K | 8.80M | 83.00M | 18.41M | 38.31M | 14.36M | 6.16M | 0.00 | 12.62M |
Income Before Tax | -40.49M | 80.82M | 43.19M | 135.22M | 145.52M | 71.12M | 117.92M | 165.19M | 188.87M | 194.66M | 222.40M | 164.01M | 140.24M | 153.19M | 148.92M | 211.46M | 131.54M | 485.78M | 13.99M | 69.74M | 32.67M | 50.47M | 39.06M | 23.10M | 64.24M | -54.27M | -57.54M |
Income Before Tax Ratio | -0.88% | 1.13% | 0.59% | 2.32% | 3.01% | 1.55% | 3.14% | 4.66% | 5.89% | 6.95% | 7.49% | 6.21% | 5.34% | 7.11% | 8.81% | 11.70% | 7.33% | 32.16% | 3.14% | 3.97% | 1.74% | 2.70% | 2.58% | 1.91% | 4.78% | -4.71% | -6.36% |
Income Tax Expense | -44.53M | 24.92M | 19.01M | 25.08M | 69.73M | 42.41M | 43.69M | 39.92M | 37.84M | 65.04M | 83.74M | 57.34M | 54.04M | 58.67M | 62.70M | 82.41M | 46.58M | 33.81M | 3.13M | 36.39M | 15.48M | 27.38M | 20.03M | 9.24M | 25.70M | -11.31M | -10.54M |
Net Income | 4.05M | 55.90M | 24.18M | 110.14M | 75.79M | 28.71M | 74.23M | 125.26M | 151.03M | 129.62M | 138.66M | 106.67M | 86.21M | 94.52M | 86.22M | 129.05M | 84.95M | 451.97M | 10.86M | 33.35M | 17.19M | 23.10M | 19.03M | 13.86M | 38.54M | -42.96M | -47.00M |
Net Income Ratio | 0.09% | 0.78% | 0.33% | 1.89% | 1.57% | 0.62% | 1.97% | 3.53% | 4.71% | 4.63% | 4.67% | 4.04% | 3.28% | 4.38% | 5.10% | 7.14% | 4.73% | 29.92% | 2.43% | 1.90% | 0.92% | 1.23% | 1.26% | 1.14% | 2.87% | -3.73% | -5.20% |
EPS | 0.16 | 2.28 | 0.97 | 4.72 | 3.27 | 1.15 | 2.78 | 4.63 | 5.51 | 4.25 | 4.10 | 3.03 | 2.18 | 2.43 | 2.33 | 3.59 | 2.40 | 12.80 | 0.31 | 1.00 | 0.53 | 0.73 | 0.62 | 0.47 | 1.24 | -1.54 | -1.78 |
EPS Diluted | 0.16 | 2.28 | 0.97 | 4.51 | 3.14 | 1.11 | 2.71 | 4.53 | 5.42 | 4.17 | 4.03 | 3.01 | 2.16 | 2.37 | 2.23 | 3.42 | 2.34 | 10.86 | 0.26 | 0.81 | 0.53 | 0.72 | 0.61 | 0.46 | 1.24 | -1.54 | -1.78 |
Weighted Avg Shares Out | 25.78M | 24.56M | 25.04M | 23.33M | 23.18M | 24.87M | 26.69M | 27.05M | 27.39M | 30.48M | 33.78M | 35.25M | 39.61M | 38.94M | 36.99M | 35.97M | 35.37M | 35.31M | 35.14M | 33.45M | 32.14M | 31.76M | 30.78M | 29.47M | 31.01M | 27.87M | 26.39M |
Weighted Avg Shares Out (Dil) | 25.78M | 24.56M | 25.04M | 24.44M | 24.16M | 25.88M | 27.36M | 27.68M | 27.88M | 31.06M | 34.44M | 35.42M | 40.00M | 39.84M | 38.62M | 37.69M | 36.36M | 41.61M | 41.44M | 41.24M | 32.39M | 31.92M | 31.20M | 30.17M | 31.01M | 27.87M | 26.39M |
Magellan Health Enhances Suicide Prevention Risk Management Program
Magellan Health Introduces Digital Cognitive Behavioral Therapy Programs for Children and Adolescents
Magellan Health Announces Market Leadership Appointments
Magellan Health Launches iMclusion – a New DEI Solution for Employers
Magellan Health Named to Newsweek's 2023 List of the “Most Trustworthy Companies in America”
Magellan Health Exceeds Benchmarks with Value-Based Reimbursement Program for Behavioral Healthcare Providers
Magellan Health Appoints Anna Sever as President of Magellan Federal
Magellan Health Opens 24-hour Crisis Line for Individuals Impacted by the School Shooting in St. Louis, Missouri
Magellan Health Opens 24-hour Crisis Line for Individuals Impacted by Hurricane Ian
Magellan Health Appoints Tom Britt as Chief Information Officer
Source: https://incomestatements.info
Category: Stock Reports